|
|
 |
|
Viewing report
|
|
|
|
Next Generation Drugs: Acceleration Through Innovation
Business Insights, March 2002
The pharmaceutical industry is now immersed in a wave of technological innovation to help accelerate drug discovery and development. However, selecting the most beneficial technological systems to reduce discovery and development timelines involves due consideration of a company''s R&D focus, pipeline commitments, synergies to enhance R&D programmes, and analysis of risk and competition. Next Generation Drugs: Acceleration through innovation is a new management report examining the technological innovations that are being employed by the pharmaceutical majors to expedite discovery research and R&D. Key areas of review include genomics, proteomics, pharmacogenomics, bioinformatics, and cheminformatics in addition to other key enabling high technology discovery and development platforms. This new report also reviews how companies are accelerating discovery through strategic collaborations, enhancement of in-house expertise, and by focusing on specific diseases or small molecules to optimize their future business plans.
Customers who bought this item also bought
Systems Biology - Key to Unlocking the Value within the Omics Revolution
Chinese Markets for Cancer Treatment Drugs
Pipeline Insight: Rheumatoid Arthritis and Osteoarthritis - Striving for innovation among me-toos
Chinese Markets for OTC Drugs
Pharmaceutical Innovation Through Academic Alliances
The Global Market For Hormonal Contraceptives and Infertility Drugs, 2005-2012
U.S. Next Generation Bio-Tools for Accelerating Bio-Pharmaceutical Drug Discovery R&D: Technologies, Opportunities and Markets
Beyond The Blockbuster Drug: Strategies For Nichebuster Drugs, Targeted Therapies and Personalized Medicine.
|
|
|
|
